dihydrocytochalasin b has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
dihydrocytochalasin B: inhibits cell motility in many eucaryotic cells
Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M | 1 |
| Nishio, K | 1 |
| Doe, M | 1 |
| Usuki, Y | 1 |
| Tanaka, T | 1 |
1 other study available for dihydrocytochalasin b and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Farnesylpyridinium, an analog of isoprenoid farnesol, induces apoptosis but suppresses apoptotic body formation in human promyelocytic leukemia cells.
Topics: Actin Cytoskeleton; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cysteine Proteinase Inhibi | 2002 |